Document Classification

Section Type: RESULTS

Text: The least squares (LS) mean change (95 % confidence interval) from baseline in HbA1c at week 24 was -0. 028 % (-0. 192 to 0. 137) in the placebo group, compared with -0. 797 % (-0. 960 to -0. 634) in the tofogliflozin 10 mg group, -1. 017 % (-1. 178 to -0. 856) in the tofogliflozin 20 mg group, and -0. 870 % (-1. 031 to -0. 709) in the tofogliflozin 40 mg group (p < 0. 0001 for the LS mean differences in all tofogliflozin groups vs placebo).